{"url_path":"/sec/vor/proxy/2026-04-27/000119312526181892","section_key":"body","section_title":"DEFA14A body","topic":"sec","document":{"doc_type":"DEFA14A","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1817229/0001193125-26-181892-index.html","accession_number":"0001193125-26-181892","cik":"0001817229","ticker":"VOR","issuer_name":"Vor Biopharma Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1817229/0001193125-26-181892-index.html","primary_entity_key":"0001817229","primary_entity_name":"Vor Biopharma Inc."},"word_count":125,"has_tables":true,"body_markdown":"DEFA14A\n\n0001817229DEFA14A00018172292025-01-012025-12-31\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n \n\n \n\nSCHEDULE 14A\n\nProxy Statement Pursuant to Section 14(a) of the\n\nSecurities Exchange Act of 1934\n\n(Amendment No.__)\n\n \n\nFiled by the Registrant ☒\n\nFiled by a Party other than the Registrant ☐\n\nCheck the appropriate box:\n\n \n\n☐\n\nPreliminary Proxy Statement\n\n☐\n\nConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))\n\n☐\n\nDefinitive Proxy Statement\n\n☒\n\nDefinitive Additional Materials\n\n☐\n\nSoliciting Material under §240.14a-12\n\n \n\nVOR BIOPHARMA INC.\n\n(Name of Registrant as Specified in its Charter)\n\nPayment of Filing Fee (Check all boxes that apply):\n\n \n\n☒\n\nNo fee required\n\n☐\n\nFee paid previously with preliminary materials\n\n☐\n\nFee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11"}